Omar Elkhateeb, MD🌎 on Twitter: "Ok #NeoEBM folks, #Paracetamol is as effective as Ibuprofen and Indomethacin for #PDA Rx. Given its safety profile, when will we consider it a standard of care?
![Ibuprofen versus indomethacin treatment of patent ductus arteriosus: comparative effectiveness and complications | HKMJ Ibuprofen versus indomethacin treatment of patent ductus arteriosus: comparative effectiveness and complications | HKMJ](https://www.hkmj.org/system/files/hkmj134080-table1.jpg)
Ibuprofen versus indomethacin treatment of patent ductus arteriosus: comparative effectiveness and complications | HKMJ
![Ibuprofen versus indomethacin treatment of patent ductus arteriosus: comparative effectiveness and complications | HKMJ Ibuprofen versus indomethacin treatment of patent ductus arteriosus: comparative effectiveness and complications | HKMJ](https://www.hkmj.org/system/files/hkmj134080-table4.jpg)
Ibuprofen versus indomethacin treatment of patent ductus arteriosus: comparative effectiveness and complications | HKMJ
![Mandatory Closure Versus Nonintervention for Patent Ductus Arteriosus in Very Preterm Infants - ScienceDirect Mandatory Closure Versus Nonintervention for Patent Ductus Arteriosus in Very Preterm Infants - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0022347616304127-ympd8470-fig-0001.jpg)
Mandatory Closure Versus Nonintervention for Patent Ductus Arteriosus in Very Preterm Infants - ScienceDirect
![Base excess and hematocrit predict response to indomethacin in very low birth weight infants with patent ductus arteriosus | Italian Journal of Pediatrics | Full Text Base excess and hematocrit predict response to indomethacin in very low birth weight infants with patent ductus arteriosus | Italian Journal of Pediatrics | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs13052-019-0706-y/MediaObjects/13052_2019_706_Fig1_HTML.png)
Base excess and hematocrit predict response to indomethacin in very low birth weight infants with patent ductus arteriosus | Italian Journal of Pediatrics | Full Text
![PDF] Intravenous paracetamol and patent ductus arteriosus closure in preterm infants | Semantic Scholar PDF] Intravenous paracetamol and patent ductus arteriosus closure in preterm infants | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/e11c93f52fcbfb9f814d077ba77ee9f4e5175db5/3-Figure1-1.png)
PDF] Intravenous paracetamol and patent ductus arteriosus closure in preterm infants | Semantic Scholar
![Outcomes in infants < 29 weeks of gestation following single-dose prophylactic indomethacin | Journal of Perinatology Outcomes in infants < 29 weeks of gestation following single-dose prophylactic indomethacin | Journal of Perinatology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41372-020-00814-9/MediaObjects/41372_2020_814_Fig1_HTML.png)
Outcomes in infants < 29 weeks of gestation following single-dose prophylactic indomethacin | Journal of Perinatology
![Patent ductus arteriosus in preterm infants: is early transcatheter closure a paradigm shift? | Journal of Perinatology Patent ductus arteriosus in preterm infants: is early transcatheter closure a paradigm shift? | Journal of Perinatology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41372-019-0506-7/MediaObjects/41372_2019_506_Fig2_HTML.png)
Patent ductus arteriosus in preterm infants: is early transcatheter closure a paradigm shift? | Journal of Perinatology
Cochrane Neonatal on Twitter: "Updated #Cochrane Neonatal review! Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants: https://t.co/u6etEpz8YU #CochraneEvidence #Neonates @cochranecollab @CochraneUK ...
![Decrease in the frequency of treatment for patent ductus arteriosus after implementation of consensus guidelines: a 15-year experience | Journal of Perinatology Decrease in the frequency of treatment for patent ductus arteriosus after implementation of consensus guidelines: a 15-year experience | Journal of Perinatology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41372-019-0432-8/MediaObjects/41372_2019_432_Fig1_HTML.png)
Decrease in the frequency of treatment for patent ductus arteriosus after implementation of consensus guidelines: a 15-year experience | Journal of Perinatology
![Decrease in the frequency of treatment for patent ductus arteriosus after implementation of consensus guidelines: a 15-year experience | Journal of Perinatology Decrease in the frequency of treatment for patent ductus arteriosus after implementation of consensus guidelines: a 15-year experience | Journal of Perinatology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41372-019-0432-8/MediaObjects/41372_2019_432_Fig1_HTML.png)
Decrease in the frequency of treatment for patent ductus arteriosus after implementation of consensus guidelines: a 15-year experience | Journal of Perinatology
![Duration of Indomethacin Treatment of the Preterm Patent Ductus Arteriosus as Directed by Echocardiography - ScienceDirect Duration of Indomethacin Treatment of the Preterm Patent Ductus Arteriosus as Directed by Echocardiography - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0022347609005617-gr1.jpg)
Duration of Indomethacin Treatment of the Preterm Patent Ductus Arteriosus as Directed by Echocardiography - ScienceDirect
![PDF] Indomethacin Tocolysis Increases Postnatal Patent Ductus Arteriosus Severity | Semantic Scholar PDF] Indomethacin Tocolysis Increases Postnatal Patent Ductus Arteriosus Severity | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7616ad4adb7f8fee7c2cc8eb7f051500ba7f1d9b/3-Table2-1.png)